tiprankstipranks
Amplia Therapeutics Ltd. (AU:ATX)
ASX:ATX

Compare Amplia Therapeutics (ATX) vs. Competitors

23 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Amplia Therapeutics
AU$0.14
AU$79.53M
-3.83
176.79%
Tryptamine Therapeutics
AU$48.52M
-9.56
3.45%
Neuren Pharmaceuticals Limited
AU$12.52
AU$1.59B
78.41
30.83%
6 Buy
0 Hold
0 Sell
Strong Buy
Paradigm Biopharmaceuticals
AU$0.33
AU$103.91M
-1.51
-24.59%
Alterity Therapeutics
AU$0.01
AU$97.88M
-2.12
0.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Zelira Therapeutics
AU$0.34
AU$5.95M
-1.39
6.38%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:ATX
Amplia Therapeutics
0.16
0.10
198.08%
AU:ENP
Tryptamine Therapeutics
0.03
>-0.01
-16.67%
AU:NEU
Neuren Pharmaceuticals Limited
12.52
3.33
36.24%
AU:PAR
Paradigm Biopharmaceuticals
0.23
-0.06
-20.69%
AU:ATH
Alterity Therapeutics
0.01
0.00
0.00%
AU:ZLD
Zelira Therapeutics
0.50
0.03
6.38%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts